Clinical trial
Post-market Study on Valiant Thoracic Stent Graft With the Captivia Delivery System in the Treatment of Descending Thoracic Aortic Diseases
NCT01775046 is registered in ClinicalTrials.gov with Medtronic Cardiovascular as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-market Study on Valiant Thoracic Stent Graft With the Captivia Delivery System in the Treatment of Descending Thoracic Aortic Diseases
- Lead sponsor
- Medtronic Cardiovascular
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 23, 2013
- Completion date
- December 9, 2021
- Enrollment
- 160 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.
aorta thoracic; traumatic rupture, aortic aneurysm, thoracic, aortic diseases, descending thoracic aortic dissection, penetrating ulcer